At ASH2017 from 9 - 12 December in Atlanta, USA, hematology professionals from around the world were able to learn about HARMONY in multiple ways: at the exhibition in the booth of the European Hematology Association, during a specially organized Network Meeting and during the ELN Breakfast Meeting.
The HARMONY Exectutive Team and Leaders of Work Packages 2 and 6 actively updated potential stakeholders, newcomers and partners present about the Alliance's latest achievements and future plans.
Click here to view the details of the HARMONY activities at ASH2017.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
